IMPORTANT REMINDER: New DEA Education Requirement on Opioid or other Substance Use Disorders Begins June 27

June 8, 2023

Beginning June 27, DEA license holders, upon initial registration or renewal, will be required to complete at least eight hours of training in the treatment or management of patients with opioid or other substance use disorders. 

To ensure you have the most accurate information, you should review the guidance issued by the DEA. Click here to find the MMA’s recommendations for members who need to complete this training. 

Latest News

University of Minnesota Physicians and Fairview Announce Deal

November 13, 2025

The years-long saga between the University of Minnesota and M Health Fairview took another twist this week as Fairview and University of Minnesota Physicians (UMP) announced a separate 10-year deal without the university's approval. 

Physicians Sought for Minnesota Drug Formulary Committee

November 13, 2025

The Office of the Minnesota Secretary of State (OSS) is accepting applications for two open physician seats on the Minnesota Drug Formulary Committee. 

Infant Formula Recalled in Wake of Botulism Outbreak

November 13, 2025

The Centers for Disease Control and Prevention (CDC) and public health officials in several states, including at the Minnesota Department of Health (MDH), are investigating a multistate outbreak of infant botulism linked to ByHeart Whole Nutrition infant formula.